We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
THYROCARE.NSE

Price
701.65
Stock movement down
-3.85 (-0.55%)
Company name
Thyrocare Technologies Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Diagnostics & Research
Market cap
37.18B
Ent value
37.81B
Price/Sales
5.97
Price/Book
7.61
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
44.28
Forward P/E
30.11
PEG
-
EPS growth
-3.35%
1 year return
12.32%
3 year return
-3.48%
5 year return
7.21%
10 year return
-
Last updated: 2025-04-12

DIVIDENDS

THYROCARE.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E44.28
Price to OCF138.02
Price to FCF138.02
Price to EBITDA107.93
EV to EBITDA109.75

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales5.97
Price to Book7.61
EV to Sales6.07

FINANCIALS

Per share

Loading...
Per share data
Current share count52.99M
EPS (TTM)15.68
FCF per share (TTM)5.03

Income statement

Loading...
Income statement data
Revenue (TTM)6.23B
Gross profit (TTM)3.20B
Operating income (TTM)1.08B
Net income (TTM)839.70M
EPS (TTM)15.68
EPS (1y forward)23.30

Margins

Loading...
Margins data
Gross margin (TTM)51.27%
Operating margin (TTM)17.37%
Profit margin (TTM)13.47%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash457.30M
Net receivables479.30M
Total current assets2.45B
Goodwill1.05B
Intangible assets27.70M
Property, plant and equipment0.00
Total assets5.97B
Accounts payable457.20M
Short/Current long term debt185.50M
Total current liabilities948.40M
Total liabilities1.08B
Shareholder's equity4.89B
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)269.40M
Capital expenditures (TTM)0.00
Free cash flow (TTM)269.40M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity17.18%
Return on Assets14.06%
Return on Invested Capital16.89%
Cash Return on Invested Capital5.42%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open709.15
Daily high714.85
Daily low697.00
Daily Volume17K
All-time high1448.10
1y analyst estimate1007.50
Beta0.44
EPS (TTM)15.68
Dividend per share-
Ex-div date16 Aug 2024
Next earnings date12 May 2025

Downside potential

Loading...
Downside potential data
THYROCARE.NSES&P500
Current price drop from All-time high-51.55%-12.89%
Highest price drop-71.00%-56.47%
Date of highest drop28 Mar 20239 Mar 2009
Avg drop from high-30.87%-11.07%
Avg time to new high60 days12 days
Max time to new high942 days1805 days
COMPANY DETAILS
THYROCARE.NSE (Thyrocare Technologies Limited) company logo
Marketcap
37.18B
Marketcap category
Large-cap
Description
Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates through three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, and various infectious diseases. Its profiles of tests include profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical products. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.
Employees
1693
Investor relations
-
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found